Bispecific T-cell engagers: Towards understanding variables influencing the in vitro potency and tumor selectivity and their modulation to enhance their efficacy and safety-Reference-Cited by-同舟云学术

Bispecific T-cell engagers: Towards understanding variables influencing the in vitro potency and tumor selectivity and their modulation to enhance their efficacy and safety

Published:2019-02 Issue: Volume:154 Page:102-117
ISSN:1046-2023
Container-title:Methods
language:en
Short-container-title:Methods

Author:

Ellerman Diego

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology,Molecular Biology

Reference179 articles.

1. CAR T cell immunotherapy for human cancer;June;Science (80),2018

2. Cytokines in the treatment of cancer;Conlon;J. Interf. Cytokine Res.,2018

3. Future prospects of immune checkpoint blockade in cancer: from response prediction to overcoming resistance;Park;Exp. Mol. Med.,2018

4. Next generation of immune checkpoint therapy in cancer: new developments and challenges;Marin-Acevedo;J. Hematol. Oncol.,2018

5. The immune revolution: a case for priming, not checkpoint;Vonderheide;Cancer Cell,2018

Cited by 149 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DARPin-fused T cell engager for adenovirus-mediated cancer therapy;Molecular Therapy: Oncology;2024-09

2. IL-2-armored peptide-major histocompatibility class I bispecific antibodies redirect antiviral effector memory CD8+ T cells to induce potent anti-cancer cytotoxic activity with limited cytokine release;mAbs;2024-08-28

3. CD64⁺fibroblast-targeted vilanterol and a STING agonist augment CLDN18.2 BiTEs efficacy against pancreatic cancer by reducing desmoplasia and enriching stem-like CD8⁺T cells;Gut;2024-08-26

4. Engineering a tumor-selective prodrug T-cell engager bispecific antibody for safer immunotherapy;mAbs;2024-07-04

5. Improving chimeric antigen receptor T-cell therapies by using artificial intelligence and internet of things technologies: A narrative review;European Journal of Pharmacology;2024-07